ScholarIQanswers from OpenAlex

4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer

PaperCitations, authors & open-access status

4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does 4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer have?

ScholarIQcitation count

4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer has 2 citations in the OpenAlex counts ScholarIQ stores.

When was 4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer published?

ScholarIQyear

4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer has 2024 year in the ScholarIQ index.

What is the open-access status of 4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer?

ScholarIQoa status

4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer has bronze oa status in the ScholarIQ index.

What is the DOI of 4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer?

ScholarIQdoi

The DOI for 4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer is on the source record.

What is the OpenAlex record for 4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer?

ScholarIQopenalex

The OpenAlex for 4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial